MIR4657: A Drug Target / Disease Biomarker (G100616393)
MIR4657: A Drug Target / Disease Biomarker
MIR4657 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR family of proteins, which are known for their role in the regulation of pain, inflammation, and cell survival. MIR4657 has been shown to have potent anti-inflammatory and analgesic properties, making it a potential drug target or biomarker.
The MIR4657 protein is composed of 214 amino acid residues and has a calculated molecular mass of 31.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. MIR4657 is a potent inhibitor of the production of inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. It also appears to inhibit the production of pro-inflammatory cytokines, such as IL-8.
In addition to its anti-inflammatory properties, MIR4657 has also been shown to have potent analgesic properties. In animal models of pain, MIR4657 has been shown to provide significant analgesia, with a dose-dependant effect on pain threshold. This suggests that MIR4657 could be a useful drug or biomarker for the treatment of pain.
MIR4657 has also been shown to have a unique expression pattern in various tissues of the body. For example, it is highly expressed in the brain, where it is present at levels of up to 20% of brain protein. It is also expressed in the heart, where it is present at levels of up to 15%. In the kidneys, MIR4657 is present at levels of up to 25%. These findings suggest that MIR4657 may have a specific role in the regulation of pain and inflammation in these tissues.
Furthermore, MIR4657 has been shown to have a unique structure-activity relationship (SAR). The SAR is a relationship between the strength of a protein and the binding of a small molecule, such as a drug or ligand. MIR4657 has a unique SAR, with a large binding site and a short half-life. This suggests that MIR4657 may have a unique mechanism of action, and may be a more targeted drug or biomarker than other proteins with similar properties.
MIR4657 has also been shown to have a potential role in the regulation of cellular processes, such as cell survival and angiogenesis. For example, MIR4657 has been shown to play a role in the regulation of cell proliferation and survival in various tissues, including the brain. It has been shown to inhibit the migration of cancer cells and to promote the growth of brain tissue.
In conclusion, MIR4657 is a protein that has been shown to have a unique role in the regulation of pain, inflammation, and cellular processes. Its potent anti-inflammatory and analgesic properties make it a potential drug target or biomarker. Further research is needed to fully understand the role of MIR4657 in these processes and its potential therapeutic applications.
Protein Name: MicroRNA 4657
More Common Targets
MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762
